These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

557 related articles for article (PubMed ID: 27819111)

  • 1. Cardiac Dysfunction, Congestion and Loop Diuretics: their Relationship to Prognosis in Heart Failure.
    Pellicori P; Cleland JG; Zhang J; Kallvikbacka-Bennett A; Urbinati A; Shah P; Kazmi S; Clark AL
    Cardiovasc Drugs Ther; 2016 Dec; 30(6):599-609. PubMed ID: 27819111
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IVC diameter in patients with chronic heart failure: relationships and prognostic significance.
    Pellicori P; Carubelli V; Zhang J; Castiello T; Sherwi N; Clark AL; Cleland JG
    JACC Cardiovasc Imaging; 2013 Jan; 6(1):16-28. PubMed ID: 23328557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In chronic heart failure with marked fluid retention, the i.v. high doses of loop diuretic are a predictor of aggravated renal dysfunction, especially in the set of heart failure with normal or only mildly impaired left ventricular systolic function.
    De Vecchis R; Ciccarelli A; Ariano C; Cioppa C; Giasi A; Pucciarelli A; Cantatrione S
    Minerva Cardioangiol; 2011 Dec; 59(6):543-54. PubMed ID: 21330961
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Global longitudinal strain in patients with suspected heart failure and a normal ejection fraction: does it improve diagnosis and risk stratification?
    Pellicori P; Kallvikbacka-Bennett A; Khaleva O; Carubelli V; Costanzo P; Castiello T; Wong K; Zhang J; Cleland JG; Clark AL
    Int J Cardiovasc Imaging; 2014 Jan; 30(1):69-79. PubMed ID: 24150723
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of short-term omission of daily medication on the pathophysiology of heart failure.
    Dovancescu S; Pellicori P; Mabote T; Torabi A; Clark AL; Cleland JGF
    Eur J Heart Fail; 2017 May; 19(5):643-649. PubMed ID: 28295907
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of adding torasemide to standard therapy on peak oxygen consumption, natriuretic peptides, and quality of life in patients with compensated left ventricular systolic dysfunction.
    Gupta S; Waywell C; Gandhi N; Clayton N; Keevil B; Clark AL; Ng LL; Brooks N; Neyses L
    Eur J Heart Fail; 2010 Jul; 12(7):746-52. PubMed ID: 20525705
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduced Diuretic Dose in Patients Treated With Eplerenone: Data From the EPHESUS Trial.
    Ferreira JP; Eschalier R; Duarte K; Damman K; Gustafsson F; Schou M; Girerd N; Fay R; Tala S; Pitt B; Zannad F; Rossignol P
    Circ Heart Fail; 2020 May; 13(5):e006597. PubMed ID: 32354280
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rational and design of a randomized, double-blind, multicenter trial to evaluate the safety and tolerability of furosemide withdrawal in stable chronic outpatients with heart failure: The ReBIC-1 trial.
    da Rosa PR; Rohde LE; Doebber M; Ribeiro ALP; Prado DP; Bertoldi EG; Figueiredo Neto JA; Kohler I; Beck-da-Silva L; Danzmann LC; Moura LZ; Rover M; Simões MV; Sant'Anna RT; Biolo A
    Am Heart J; 2017 Dec; 194():125-131. PubMed ID: 29223430
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Left atrial function measured by cardiac magnetic resonance imaging in patients with heart failure: clinical associations and prognostic value.
    Pellicori P; Zhang J; Lukaschuk E; Joseph AC; Bourantas CV; Loh H; Bragadeesh T; Clark AL; Cleland JG
    Eur Heart J; 2015 Mar; 36(12):733-42. PubMed ID: 25336215
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incremental value of N-terminal pro-brain natriuretic peptide over left ventricle ejection fraction and aerobic capacity for estimating prognosis in heart failure patients.
    Kallistratos MS; Dritsas A; Laoutaris ID; Cokkinos DV
    J Heart Lung Transplant; 2008 Nov; 27(11):1251-6. PubMed ID: 18971099
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Malnutrition, congestion and mortality in ambulatory patients with heart failure.
    Sze S; Pellicori P; Zhang J; Clark AL
    Heart; 2019 Feb; 105(4):297-306. PubMed ID: 30121635
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of admission oral diuretic dose on response to continuous versus bolus intravenous diuretics in acute heart failure: an analysis from diuretic optimization strategies in acute heart failure.
    Shah RV; McNulty S; O'Connor CM; Felker GM; Braunwald E; Givertz MM
    Am Heart J; 2012 Dec; 164(6):862-8. PubMed ID: 23194486
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combining Loop and Thiazide Diuretics Across the Left Ventricular Ejection Fraction Spectrum: The CLOROTIC Trial.
    Sánchez-Marteles M; Garcés-Horna V; Morales-Rull JL; Casado J; Carrera-Izquierdo M; Conde-Martel A; Dávila-Ramos MF; Llácer P; Salamanca-Bautista P; Ruiz R; Aramburu-Bodas O; Formiga F; Manzano L; Trullàs JC
    JACC Heart Fail; 2024 Oct; 12(10):1719-1730. PubMed ID: 38934966
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Congestive heart failure and decongestion ability of two different treatments: continuous renal replacement and diuretic therapy: experience of a cardiac step down unit.
    Giglioli C; Spini V; Landi D; Chiostri M; Romano SM; Calabretta R; Gensini GF; Cecchi E
    Acta Cardiol; 2013 Aug; 68(4):355-64. PubMed ID: 24187761
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased left atrial volume index is an independent predictor of raised serum natriuretic peptide in patients with suspected heart failure but normal left ventricular ejection fraction: Implication for diagnosis of diastolic heart failure.
    Lim TK; Ashrafian H; Dwivedi G; Collinson PO; Senior R
    Eur J Heart Fail; 2006 Jan; 8(1):38-45. PubMed ID: 16115798
    [TBL] [Abstract][Full Text] [Related]  

  • 16. N-terminal pro brain natriuretic peptide-guided management in patients with heart failure and preserved ejection fraction: findings from the Trial of Intensified versus standard medical therapy in elderly patients with congestive heart failure (TIME-CHF).
    Maeder MT; Rickenbacher P; Rickli H; Abbühl H; Gutmann M; Erne P; Vuilliomenet A; Peter M; Pfisterer M; Brunner-La Rocca HP;
    Eur J Heart Fail; 2013 Oct; 15(10):1148-56. PubMed ID: 23657728
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design and baseline characteristics of SALT-HF trial: hypertonic saline therapy in ambulatory heart failure.
    Cobo Marcos M; Comín-Colet J; de la Espriella R; Rubio Gracia J; Morales-Rull JL; Zegrí I; Llacer P; Diez-Villanueva P; Jiménez-Marrero S; de Juan Bagudá J; Ortiz Cortés C; Goirigolzarri-Artaza J; García-Pinilla JM; Barrios E; Del Prado Díaz S; Montero Hernández E; Sanchez-Marteles M; Nuñez J
    ESC Heart Fail; 2024 Jun; 11(3):1767-1776. PubMed ID: 38380837
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes in plasma N-terminal proBNP levels and ventricular filling pressures during intensive unloading therapy in elderly with decompensated congestive heart failure and preserved left ventricular systolic function.
    Cioffi G; Tarantini L; Stefenelli C; Azzetti G; Marco R; Carlucci S; Furlanello F
    J Card Fail; 2006 Oct; 12(8):608-15. PubMed ID: 17045179
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adding point of care ultrasound to assess volume status in heart failure patients in a nurse-led outpatient clinic. A randomised study.
    Gundersen GH; Norekval TM; Haug HH; Skjetne K; Kleinau JO; Graven T; Dalen H
    Heart; 2016 Jan; 102(1):29-34. PubMed ID: 26438785
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intravenous Diuretic Therapy for the Management of Heart Failure and Volume Overload in a Multidisciplinary Outpatient Unit.
    Buckley LF; Carter DM; Matta L; Cheng JW; Stevens C; Belenkiy RM; Burpee LJ; Young MA; Weiffenbach CS; Smallwood JA; Stevenson LW; Desai AS
    JACC Heart Fail; 2016 Jan; 4(1):1-8. PubMed ID: 26656139
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.